# Spironolactone on Acute Kidney Injury in Critically Ill Patients

> **NCT03206658** · PHASE3 · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 90 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Spironolactone 25 mg
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03206658
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-07-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03206658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03206658, "Spironolactone on Acute Kidney Injury in Critically Ill Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03206658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*